Serrated adenocarcinomas, which account for 20–30% of CRC, follow an alternative pathway independent of APC mutations, in which serrated polyps replace traditional adenoma as the CRC precursor lesion [42]. The gene discussed is APC; the disease is adenocarcinoma.